Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Summit Therapeutics plc : Miscellaneous

Summit Therapeutics plc
Posted on: 16 Nov 17

Summit Therapeutics plc
("Summit" or the "Company")


Oxford, UK, 16 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infection, announces the appointment of Panmure Gordon as joint broker with immediate effect to act alongside N+1 Singer.

About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programmes focused on the genetic disease Duchenne muscular dystrophy and the infectious disease C. difficile infection. Further information is available at and Summit can be followed on Twitter (@summitplc).


Glyn Edwards / Richard Pye (UK office)
Erik Ostrowski / Michelle Avery (US office)


Tel: +44 (0)1235 443 951
  +1 617 225 4455
Cairn Financial Advisers LLP (Nominated Adviser)
Liam Murray / Tony Rawlinson

Tel: +44 (0)20 7213 0880
N+1 Singer (Joint Broker)
Aubrey Powell / Jen Boorer 

Tel: +44 (0)20 7496 3000
Pamure Gordon (Joint Broker)
Freddy Crossley / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
Tel: +44 (0)20 7886 2500
MacDougall Biomedical Communications (US)
Karen Sharma
Tel: +1 781 235 3060

Consilium Strategic Communications (UK)
Mary-Jane Elliott / Sue Stuart /
Jessica Hodgson / Philippa Gardner
Tel: +44 (0)20 3709 5700


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Summit Therapeutics plc via GlobeNewswire

Last updated on: 17/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.